Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price shot up 21.2% during trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares were traded during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Down 10.0 %
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market cap of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company has a 50 day moving average price of C$0.11 and a two-hundred day moving average price of C$0.08.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Fintech Stocks With Good 2021 Prospects
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How to Invest in the FAANG Stocks
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
